BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for July 3, 2023

July 3, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lunit.
Read More

In the clinic for July 3, 2023

July 3, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Capricor, Cyclo, Enterome, Genfit, Ipsen, Kyverna, Neuren, Pharmaessentia, PTC, Sanofi Pasteur, SK.
Read More

In the clinic for June 30, 2023

June 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioheart, Castle Biosciences, Novigenix.
Read More

In the clinic for June 30, 2023

June 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akebia, Aldeyra,  Alumis, Amytrx, Astrazeneca, Biontech, Bioxcel, Delsitech, Haemalogix, Intrabio, Jacobio, Junshi, Nanoviricides, Oncoc4, Plus, Renovorx, Urica.
Read More

In the clinic for June 29, 2023

June 29, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Renovorx.
Read More

In the clinic for June 29, 2023

June 29, 2023

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amplifica, Anavex, Astellas, Bayer, Blue Earth, Caliway, Carisma, Checkpoint, Cognition, Corcept, First Wave, Foghorn, Genmab, Karyopharm, Microba, Neuren, Panbela, Prothena, Regeneron, Rezolute, Spago, Stellas, Taysha Gene Therapies, Tme, Verona, Viracta.


Read More

In the clinic for June 28, 2023

June 28, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ciliatech, Intrinsic Therapeutics, Neurometrix.
Read More

In the clinic for June 28, 2023

June 28, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adicet, Aldeyra, Aveo, Bavarian Nordic, Biorestorative, Bioxytran, Black Diamond, Cassava, Edgewise, Eli Lilly, Freya, Harpoon, Idorsia, Inozyme, Lobe, Meiragtx, Minervax, Nkarta, Regulus, Sanofi.
Read More

In the clinic for June 20-26, 2023

June 27, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aslan, Biocity, Curocell, Horizon, Invivyd, Minghui, Sumitomo, Takeda, Telix.
Read More

In the clinic for June 27, 2023

June 27, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Senseonics, Vida Health.
Read More
Previous 1 2 … 130 131 132 133 134 135 136 137 138 … 322 323 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing